Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Certara Introduces Integral, its Next-generation Data Repository

Published

on

Reading Time: 3 minutes

It is a multi-functional, cloud-based, 21 CFR Part 11 compliant
platform for clinical pharmacology, pharmacometrics and clinical
operations professionals

PRINCETON, N.J.–(BUSINESS WIRE)–Certara® the global leader in model-informed drug development,
regulatory science, real-world evidence and market access services,
today announced the introduction of Certara Integral™, its
next-generation data repository for collecting, managing, and storing
multiple types of data sets for analysis, sharing and reporting of
clinical pharmacology, pharmacometrics and other relevant clinical data.

“As the amount and accessibility of clinical and regulatory data has
exploded, so has the need for systems and infrastructure that can
streamline complex decision-making,” said Michael Eckstut, senior vice
president and head of Certara’s pharmacometrics software group. “In
developing Integral, we combined the knowledge gained by our 175 drug
development, clinical pharmacology and pharmacometrics scientific
experts, with the software development skills of our pharmacometrics and
scientific informatics teams to create a unique multi-functional
product. We believe that Integral will follow the adoption curve
established by Certara’s other industry-leading technologies, such as
Phoenix®, D360™, and Simcyp®.”

Certara Integral™ combines the attributes of a software-agnostic data
warehouse with a workflow-driven tracking and retrieval toolkit housed
in a cloud-based, 21 CFR Part 11 compliant infrastructure. Data are
highly organized and can be categorized by clinical study, project, and
individual experiments, enabling users to ask ‘what if’ questions at all
levels. Integral allows users, and their associated partners, to
interact with multiple sources and types of data via client apps,
plug-ins and APIs. Certara Integral™ is agnostic with respect to the
type of analytical tool or data used by the customer.

Recognizing the tremendous scientific advances occurring in
translational medicine, Certara has added the new concept of linking
study files into Integral. Linking allows multiple and cross-study
analyses to be anchored by a single file stored in a single location.
This allows users to compare multiple research scenarios and apply
different queries to guide decision-making, while maintaining an audit
trail. To facilitate visualization of results, Certara Integral™ has
optimized viewing panes, which are accessible via an Integral web app.

“Our clients were becoming overwhelmed with the number of disparate
tools and amount of data they had to manage, and asked us to create a
system that would enable them to quickly organize, categorize, retrieve,
visualize and analyze their PK data,” said Kevin Trimm, product manager
for Certara’s pharmacometrics software portfolio. “We listened and
created a repository that will meet their PK needs today, and expand
into other clinical and non-clinical data storage and analysis areas in
future iterations. For example, Certara Integral™ will connect all PK
CDISC domains out of the box, and will be expanded to cover all SDTM and
SEND domains in the future.”

Certara will be hosting a one-hour webinar entitled “Next-generation
Data Repository for Clinical Pharmacology & Pharmacometrics” to
introduce Certara Integral™ and cover its most important attributes on
May 29 at 11 am EDT. Interested parties can register for the
complimentary webinar here.

About Certara

Certara enables superior drug development and patient care
decision-making through model-informed drug development, regulatory
science, real-world evidence solutions and knowledge integration. As a
result, it optimizes R&D productivity, commercial value and patient
outcomes. Its clients include hundreds of global biopharmaceutical
companies, leading academic institutions, and key regulatory agencies
across 60 countries. For more information, visit www.certara.com.

Contacts

Advertisement
Stake.com

Certara Contact:
Ellen Leinfuss, 609-216-9586
Chief
Corporate Affairs Officer

Media Contact:
Lisa Osborne, 206-992-5245
Rana
Healthcare Solutions
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Global Medical Cannabis Market Size To Worth USD 121.33 Billion By 2033 | CAGR Of 21.30%

Published

on

Continue Reading

Cannabis

Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET

Published

on

Continue Reading

Cannabis

Global Industrial Hemp Market Size To Worth USD 24.30 Billion By 2033 | CAGR Of 16.27%

Published

on

Continue Reading
Advertisement
Stake.com

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania